Additional Transcription Factor Compounds Products
18 results for "Additional Transcription Factor Compounds" in Products
18 results for "Additional Transcription Factor Compounds" in Products
Additional Transcription Factor Compounds Products
Core binding factor inhibitor; attenuates hematopoiesis
| Alternate Names: | CBFβ-Runx1 inhibitor II |
| Chemical Name: | 7-Chloro-1,3-dihydro-5-(1H-pyrrol-2-yl)-2H-1,4-benzodiazepin-2-one |
| Purity: | ≥98% (HPLC) |
YAP inhibitor
| Alternate Names: | Visudyne |
| Chemical Name: | (4R,4aS)-18-Ethenyl-4,4a-dihydro-3,4-bis(methoxycarbonyl)-4a,8,14,19-tetramethyl-24H,26H-benzo[b]porphine-9,13-dipropanoic acid monomethyl ester |
| Purity: | ≥95% (HPLC) |
Potent and selective Foxo1 inhibitor; orally bioavailable
| Chemical Name: | 5-Amino-7-(cyclohexylamino)-1-ethyl-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid |
| Purity: | ≥98% (HPLC) |
Hepatocyte nuclear factor 4α (HNF4α) antagonist
| Chemical Name: | 2-Methyl-1-[(2-methyl-5-nitrophenyl)sulfonyl]-1H-benzimidazole |
| Purity: | ≥98% (HPLC) |
Potent and selective CREB inhibitor
| Chemical Name: | 3-(3-Aminopropoxy)-N-[2-[[3-[[(4-chloro-2-hydroxyphenyl)amino]carbonyl]-2-naphthalenyl]oxy]ethyl]-2-naphthalenecarboxamide hydrochloride |
| Purity: | ≥98% (HPLC) |
Cryptochrome protein stabilizer; lengthens circadian period
| Chemical Name: | N-[3-(9H-Carbazol-9-yl)-2-hydroxypropyl]-N-(2-furanylmethyl)methanesulfonamide |
| Purity: | ≥98% (HPLC) |
GLI antagonist; inhibits Hedgehog (Hh) signaling
| Chemical Name: | 2,2'-[[Dihydro-2-(4-pyridinyl)-1,3(2H,4H)-pyrimidinediyl]bis(methylene)]bis[N,N-dimethylbenzenamine |
| Purity: | ≥98% (HPLC) |
Selective inhibitor of ATF6α; sensitizes cells to ER stress
| Chemical Name: | N-[1-[[2,4-bis(Trifluoromethyl)phenyl]methyl]-1H-pyrazol-4-yl]-5-(2-furanyl)-3-isoxazolecarboxamide |
| Purity: | ≥98% (HPLC) |
TRIM24 Degrader (PROTAC®)
| Chemical Name: | (2S,4R)-1-((S)-15-(tert-Butyl)-1-(3-(N-(1,3-dimethyl-2-oxo-6-(3-propoxyphenoxy)-2,3-dihydro-1H-benzo[d]imidazol-5-yl)sulfamoyl)phenyl)-1,13-dioxo-5,8,11-trioxa-2,14-diazahexadecan-16-oyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide |
| Purity: | ≥98% (HPLC) |
Steroid receptor coactivator 3 (SRC-3) inhibitor
| Chemical Name: | 1-(2-Pyridinyl)ethanone 2-(1-methyl-1H-benzimidazol-2-yl)hydrazone hydrochloride |
| Purity: | ≥98% (HPLC) |
Selective Smad3 inhibitor; inhibits TGF-βR1 signaling
| Chemical Name: | 1,2,3,4-Tetrahydro-6,7-dimethoxy-2-[(2E)-3-(1-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl)-1-oxo-2-propenyl]-isoquinoline hydrochloride |
| Purity: | ≥97% (HPLC) |
HSF1 inhibitor
| Chemical Name: | N2-1H-Indazol-5-yl-N6-methyl-3-nitro-2,6-pyridinediamine |
| Purity: | ≥99% (HPLC) |
High affinity Nur77 agonist
| Chemical Name: | Ethyl 3,5-dihydroxy-2-(1-oxooctyl)-benzeneacetate |
| Purity: | ≥98% (HPLC) |
Brachyury down modulator
| Chemical Name: | (E)-4-(Dimethylamino)-N-[1-[4-fluoro-3-(2,2,2-trifluoroethoxy)anilino]-6-methoxy-7-isoquinolyl]but-2-enamide |
| Purity: | ≥98% (HPLC) |
Potent and reversible inhibitor of TEAD mediated Hippo/Yap signalling
| Chemical Name: | 4-[3-(2-Cyclohexylethoxy)benzoyl]-N-phenyl-1-piperazinecarboxamide |
| Purity: | ≥98% (HPLC) |
Inhibits c-Myc-Max dimerization
| Chemical Name: | 5-[(4-Ethylphenyl)methylene]-2-thioxo-4-thiazolidinone |
| Purity: | ≥99% (HPLC) |
High affinity Myc inhibitor
| Chemical Name: | 4-[2-(2-Furanyl)-6-(4-nitrophenyl)-4-pyridinyl]benzamide |
| Purity: | ≥98% (HPLC) |
